Your Gateway to GMP Compliance and Pharmaceutical Excellence
Implement CAPA Based on Trend Analysis for Effective GMP Compliance Drive CAPA Actions Through Trend Analysis in GMP Quality Systems Remember: Always use data trends — not just individual events — to drive Corrective and Preventive Actions (CAPAs) in GMP operations for long-term process control. Why This Matters in GMP CAPA systems are central to…
Read More “Implement CAPA Based on Trend Analysis for Effective GMP Compliance” »
Assign Responsibility Matrix for Managing GMP Deviations Assign a Clear Responsibility Matrix for Deviation Management Remember: Always define roles and responsibilities for deviation reporting and investigation to ensure swift action and cross-functional compliance. Why This Matters in GMP Deviations are any unplanned events or departures from established processes, procedures, or specifications in GMP environments. Their…
Read More “Assign Responsibility Matrix for Managing GMP Deviations” »
Always Investigate Weight Discrepancies in Finished Goods Before Release Investigate All Weight Discrepancies in Finished Goods Before GMP Release Remember: GMP mandates that any discrepancy in the weight of finished goods must be promptly investigated and resolved prior to product release. Why This Matters in GMP Final weight reconciliation is one of the last and…
Read More “Always Investigate Weight Discrepancies in Finished Goods Before Release” »
Never Blend Different Product Lots Without Prior QA Approval Do Not Blend Product Lots Without QA-Approved Justification Remember: GMP strictly forbids blending of different product lots unless there is written QA approval supported by scientific and regulatory justification. Why This Matters in GMP Blending of lots, especially without understanding the root cause of rejection or…
Read More “Never Blend Different Product Lots Without Prior QA Approval” »
Document All OOS Investigations Within Prescribed GMP Timelines Ensure OOS Investigations Are Documented Within GMP Timelines Remember: All Out-of-Specification (OOS) results must be documented and investigated within defined timelines to maintain data integrity and GMP compliance. Why This Matters in GMP Out-of-Specification (OOS) results signal that a product may not meet quality standards, and prompt…
Read More “Document All OOS Investigations Within Prescribed GMP Timelines” »
Do Not Reprocess Materials Without QA-Approved Protocol in GMP Never Reprocess Materials Without QA-Approved GMP Protocol Remember: GMP strictly prohibits material reprocessing unless it is pre-approved by QA through a validated, documented protocol. Why This Matters in GMP Reprocessing refers to the introduction of intermediate or final product back into the process due to failure…
Read More “Do Not Reprocess Materials Without QA-Approved Protocol in GMP” »
Document Utility Failure Impacts on Products to Maintain GMP Traceability Document Impact of Utility Failures on GMP Product Batches Remember: Utility disruptions such as power, HVAC, water, or compressed air failures must be documented with batch impact analysis to comply with GMP traceability requirements. Why This Matters in GMP Utilities play a vital role in…
Read More “Document Utility Failure Impacts on Products to Maintain GMP Traceability” »
Never Handle Rejected Goods During Active GMP Production Rejected Goods Must Not Be Handled During Batch Production Remember: GMP requires that rejected goods be segregated and not accessed during live production to prevent cross-contamination or mix-ups. Why This Matters in GMP Rejected materials, whether due to deviation, damage, or test failure, are considered unfit for…
Read More “Never Handle Rejected Goods During Active GMP Production” »
Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas Rejected Units Must Not Be Stored in Dispensing Areas Remember: Rejected materials should be promptly removed from dispensing areas to prevent mix-ups, cross-contamination, or unauthorized usage. Why This Matters in GMP Dispensing areas are reserved for handling approved materials that meet all quality specifications. Keeping rejected…
Read More “Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas” »